Well Told Grants

Federal grant recipients / Utah

Federal grants to Curza Inc

Salt Lake City, Utah · Small businesses · UEI VGN5BH7K3DN9

Curza Inc in Salt Lake City, Utah received $10.8 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Allergy and Infectious Diseases Research, with $10.8 million. In fiscal 2025 it was awarded $2.9 million.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Curza Inc by fiscal year
Fiscal yearAwardsAmount
FY 20212$3.0 million
FY 20221$1.0 million
FY 20231$966,962
FY 20243$3.0 million
FY 20253$2.9 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Curza Inc

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Allergy and Infectious Diseases Research 93.8555$10.8 million

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services5$10.8 million

Largest awards

The 5 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
A new class of broad-spectrum antibacterial agents to treat multi-drug resistant pathogens - project summary curza is developing the CZ-02 platform of broad-spectrum antibiotics as a new class focusing on multidrug- resistant (MDR) gram-negative pathogens that will also be efficacious against gram-p
ASST_NON_R44AI170297_075 on USAspending
Allergy and Infectious Diseases ResearchJuly 21, 2023$2.9 million
New oral antibiotics focused on treating mdr gram-negative infections - project summary cŪrza is developing a new class of broad-spectrum antibiotics, focused on multidrug-resistant (MDR) gram- negative pathogens. The CZ-02 program is directed towards inhibitors that bind to a unique site on the bac
ASST_NON_R44AI186898_075 on USAspending
Allergy and Infectious Diseases ResearchJuly 9, 2024$2.0 million
A new class of broad-spectrum antibacterials for treating mdr infections
ASST_NON_R44AI152665_075 on USAspending
Allergy and Infectious Diseases ResearchApril 2, 2021$2.0 million
A new class of antibiotic to address antimicrobial resistance - project summary cŪrza is developing a new class of broad-spectrum antibiotics, focused on multidrug-resistant (MDR) gram- negative pathogens. The CZ-02 program is directed towards compounds that bind to a unique site on the bacterial ri
ASST_NON_R44AI184155_075 on USAspending
Allergy and Infectious Diseases ResearchApril 30, 2024$2.0 million
Broad spectrum antibacterials selectively targeting an un-drugged site on the ribosome
ASST_NON_R01AI132304_075 on USAspending
Allergy and Infectious Diseases ResearchJune 25, 2021$2.0 million

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Curza Inc get?

$10.8 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Curza Inc the most?

The Department of Health and Human Services, with $10.8 million in 5 awards.

What is Curza Inc's largest federal grant?

$2.9 million under Allergy and Infectious Diseases Research, with its first action in the period on July 21, 2023. That counts only the money obligated in fiscal 2021 to 2025.

Other grant recipients in Salt Lake City

Largest federal grant recipients in Utah · Federal grants in Utah